Eagle Pharmaceuticals Inc

NASDAQ:EGRX  
35.91
+0.43 (+1.21%)
4:15:39 PM EDT: $35.91 0.00 (0.00%)
Earnings Announcements

Eagle Pharmaceuticals Reports Third Quarter 2022 Results

Published: 11/07/2022 11:56 GMT
Eagle Pharmaceuticals Inc (EGRX) - Eagle Pharmaceuticals Reports Third Quarter 2022 Results.
Total Revenue for Q3 2022 Was $65.9 Million.
Qtrly Net Loss $0.27.
Qtrly Adjusted EPS $1.12.
Revenue is expected to be $66.71 Million
Adjusted EPS is expected to be $0.90

Next Quarter Revenue Guidance is expected to be $60.65 Million
Next Quarter EPS Guidance is expected to be $0.93

More details on our Analysts Page.